In this podcast, Mandi Clark highlights Biomere’s expanding portfolio of MSD assays to analyze inflammation and disease relevant biomarkers in disease model samples for pharmacology, ADME and toxicology studies. The MSD platform is optimized for multiplex and singleplex analysis using small sample volumes.
